MA27187A1 - Methodes et compositions pour le traitement de la toxicite gastro-intestinale provoquee par la therapie cytoablative - Google Patents
Methodes et compositions pour le traitement de la toxicite gastro-intestinale provoquee par la therapie cytoablativeInfo
- Publication number
- MA27187A1 MA27187A1 MA27866A MA27866A MA27187A1 MA 27187 A1 MA27187 A1 MA 27187A1 MA 27866 A MA27866 A MA 27866A MA 27866 A MA27866 A MA 27866A MA 27187 A1 MA27187 A1 MA 27187A1
- Authority
- MA
- Morocco
- Prior art keywords
- cytoablative
- methods
- gastrointestinal toxicity
- compositions
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention porte sur des préparations pharmaceutiques et méthodes pour soulager ou réduire la toxicité gastro-intestinale et la dysfonction provoquées par la thérapie cytoablative, oé des peptides immunomodulateurs sont utilisés soit seuls soit en combinaison avec d'autres agents thérapeutiques. Il est aussi donné des améliorations de thérapie cytoablative contre le cancer, oé l'administration des peptides traités en conjonction avec la thérapie cytoablative permet l'administration de doses maximum tolérées plus importantes du/des agent(s) cytoablatif(s) pour améliorer l'efficacité et la réponse à la tumeur.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36021102P | 2002-02-26 | 2002-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27187A1 true MA27187A1 (fr) | 2005-01-03 |
Family
ID=27766201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27866A MA27187A1 (fr) | 2002-02-26 | 2004-09-20 | Methodes et compositions pour le traitement de la toxicite gastro-intestinale provoquee par la therapie cytoablative |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040110687A1 (fr) |
EP (1) | EP1485118A2 (fr) |
JP (1) | JP2005524650A (fr) |
KR (1) | KR20040094745A (fr) |
CN (1) | CN1642568A (fr) |
AU (1) | AU2003219971A1 (fr) |
CA (1) | CA2477231A1 (fr) |
CO (1) | CO5611158A2 (fr) |
IL (1) | IL163718A0 (fr) |
MA (1) | MA27187A1 (fr) |
MX (1) | MXPA04008290A (fr) |
NO (1) | NO20044064L (fr) |
RU (1) | RU2004128444A (fr) |
WO (1) | WO2003072061A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053727A2 (fr) * | 2003-11-29 | 2005-06-16 | Sangstat Medical Corporation | Compositions pharmaceutiques pour agents peptidiques bioactifs |
US20080312201A1 (en) * | 2004-09-10 | 2008-12-18 | Patrick Fogarty | Reduced Toxicity Methotrexate Formulations and Methods for Using the Same |
CN101804197B (zh) * | 2010-05-21 | 2012-05-23 | 魏华 | 一种用于癌症骨转移的药物组合物及其用途 |
ES2965906T3 (es) * | 2013-09-13 | 2024-04-17 | Soligenix Inc | Péptidos para su uso en el tratamiento de la mucositis oral |
US11311598B2 (en) | 2013-09-13 | 2022-04-26 | Soligenix, Inc. | Peptides and analogs for use in the treatment of oral mucositis |
CN111533802B (zh) * | 2020-05-09 | 2022-05-17 | 清华大学深圳国际研究生院 | S-腺苷同型半胱氨酸人工完全抗原、制备方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385888A (en) * | 1987-03-20 | 1995-01-31 | The Regents Of The University Of California | Class I MHC modulation or surface receptor activity |
US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
US6162434A (en) * | 1995-05-03 | 2000-12-19 | Sangstat Medical Corporation | Cytomodulating peptide for inhibiting lymphocyte activity |
US5753625A (en) * | 1995-05-12 | 1998-05-19 | Sangstat Medical Corporation | Treatment for inhibiting the progression of autoimmune disease |
NZ500287A (en) * | 1997-04-11 | 2002-10-25 | Sangstat Medical Corp | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
-
2003
- 2003-02-26 US US10/376,647 patent/US20040110687A1/en not_active Abandoned
- 2003-02-26 IL IL16371803A patent/IL163718A0/xx unknown
- 2003-02-26 MX MXPA04008290A patent/MXPA04008290A/es not_active Application Discontinuation
- 2003-02-26 EP EP03716258A patent/EP1485118A2/fr not_active Withdrawn
- 2003-02-26 WO PCT/US2003/006333 patent/WO2003072061A2/fr not_active Application Discontinuation
- 2003-02-26 JP JP2003570808A patent/JP2005524650A/ja active Pending
- 2003-02-26 KR KR10-2004-7013390A patent/KR20040094745A/ko not_active Application Discontinuation
- 2003-02-26 AU AU2003219971A patent/AU2003219971A1/en not_active Abandoned
- 2003-02-26 CA CA002477231A patent/CA2477231A1/fr not_active Abandoned
- 2003-02-26 CN CNA038071843A patent/CN1642568A/zh active Pending
- 2003-02-26 RU RU2004128444/14A patent/RU2004128444A/ru not_active Application Discontinuation
-
2004
- 2004-09-20 MA MA27866A patent/MA27187A1/fr unknown
- 2004-09-23 CO CO04094999A patent/CO5611158A2/es not_active Application Discontinuation
- 2004-09-24 NO NO20044064A patent/NO20044064L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL163718A0 (en) | 2005-12-18 |
KR20040094745A (ko) | 2004-11-10 |
CA2477231A1 (fr) | 2003-09-04 |
CN1642568A (zh) | 2005-07-20 |
JP2005524650A (ja) | 2005-08-18 |
WO2003072061A3 (fr) | 2004-07-08 |
NO20044064L (no) | 2004-11-18 |
RU2004128444A (ru) | 2005-06-10 |
MXPA04008290A (es) | 2004-11-26 |
EP1485118A2 (fr) | 2004-12-15 |
US20040110687A1 (en) | 2004-06-10 |
AU2003219971A1 (en) | 2003-09-09 |
WO2003072061A2 (fr) | 2003-09-04 |
CO5611158A2 (es) | 2006-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316082A (pt) | Métodos de tratar ou prevenir e de controlar uma doença mieloproliferative, de reduzir ou evitar um efeito adverso associado com a administração de um segundo agente ativo em um paciente sofrendo de uma doença mieloproliferativa e de aumentar a eficácia terapêutica de um tratamento de doenças mieloproliferativa, composição farmacêutica e kit | |
CY1116215T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
LU92642I2 (fr) | Pomalidomide et ses sels, solvates, hydrates ou stéréoisomères pharmaceutiquement acceptables qui endérivent (Imnovid) | |
NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
BR0316050A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
WO2003094836A3 (fr) | Methodes et produits permettant d'ameliorer des reponses immunitaires a l'aide de compose d'imidazoquinoline | |
EA200100872A1 (ru) | Композиция валдекоксиба | |
DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
WO2001066123A3 (fr) | Composition d'herbe medicinale phy906 et son utilisation en chimiotherapie | |
WO2002078627A3 (fr) | Composition de n-acetylcysteine et methodes de traitement et de prevention de la toxicite des medicaments | |
SG148169A1 (en) | Combination drug therapy to treat obesity | |
TNSN06403A1 (en) | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
HUP0400548A2 (hu) | Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
JP2006516571A5 (fr) | ||
BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
BRPI0413410A (pt) | co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer | |
WO2001010387A3 (fr) | Utilisation de modulateurs de p-glycoproteine dans un traitement antiviral | |
NO931886L (no) | Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning | |
MA27187A1 (fr) | Methodes et compositions pour le traitement de la toxicite gastro-intestinale provoquee par la therapie cytoablative | |
ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
EA200801731A1 (ru) | Составы и способы лечения тробмоцитемии | |
DK1383516T3 (da) | Indgivelse af et polysaccharid samtidig med et kemoterapeutisk middel til behandling af cancer |